1. HBW Insight
  2. >>Beauty

CIR Panel’s ‘Ethereal’ Role In Cosmetics Regulation Not Clarified By MoCRA

 
• By Lauren Nardella

While other legislative proposals to update US cosmetics regulations would have included FDA ingredient review or codified reviews from the CIR Expert Panel for Cosmetic Ingredient Safety, the Modernization of Cosmetic Regulations Act of 2022 does not. Panelists, industry and FDA reps discussed implications for CIR at the 5-6 March meeting of the group’s independent expert panel.

The Modernization of Cosmetic Regulations Act of 2022 does not create a framework for systematic cosmetic ingredient review at the US Food and Drug Administration, as other cosmetics reform proposals would have, but does include new requirements for substantiating the safety of cosmetic products.

Arguably that could make the work of Cosmetic Ingredient Review’s independent Expert Panel for Cosmetic

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation